VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a significant increase in the powerful capabilities of its QIAcuity Digital PCR (dPCR) system ...
Explore digital PCR’s potential, how the technology has transformed life science research, the challenges it faces and what ...
Discover the principles behind Countable PCR, how it compares with established molecular quantification methods, and what direct RNA counting could mean for research and clinical applications.
The Michigan startup uses a proprietary approach called processor-mediated PCR to enable high-plex, low-cost testing in a ...
PCR is a well-established technique, and over the past decade, it has been adapted to quantify RNA and DNA quicker and more accurately. Multiplex PCR technologies have been developed to increase the ...
High-throughput discovery technologies deliver an astounding quantity of data but often the greater challenge is to identify real targets from the vast body of potential hits. Typically, this task ...
The changing technology landscape will affect the BioWatch program. This chapter comments on additional assay performance considerations that arise from the use of multiplexed real-time polymerase ...
In vitro diagnostics (IVD) is an umbrella term for tests conducted on blood or tissue samples to detect diseases, determine the efficacy of novel or established treatments, and monitor health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results